Helix BioMedix Inc. (OTCMKTS:HXBM – Get Free Report) saw a significant drop in short interest in the month of September. As of September 15th, there was short interest totaling 87 shares, a drop of 57.4% from the August 31st total of 204 shares. Based on an average daily volume of 901 shares, the days-to-cover ratio is currently 0.1 days. Approximately 0.0% of the shares of the company are sold short.
Helix BioMedix Stock Performance
OTCMKTS HXBM opened at $4.40 on Wednesday. The company has a 50 day moving average of $3.21 and a 200-day moving average of $2.09. Helix BioMedix has a 1-year low of $1.00 and a 1-year high of $6.50.
Helix BioMedix Company Profile
Helix BioMedix, Inc is a biotechnology company focused on the discovery, development and commercialization of bioactive peptides for personal-care, cosmetic and related life-science applications. Its work centers on peptides designed to support skin health and appearance, including products used in anti-aging, skin-repair and antimicrobial formulations.
The company develops proprietary peptide ingredients and licenses or supplies them to manufacturers and formulators for use in skincare and other topical products.
Further Reading
- Five stocks we like better than Helix BioMedix
- The Bull Case for Amprius Technologies Just Got Stronger
- CarMax Just Gave Investors a Better Reason to Believe in the Turnaround
- CoreWeave Comes With Risks: Analysts Split on What Matters Most
- Bottlenecking the Future: TSMC Prices Out the Competition
Receive News & Ratings for Helix BioMedix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helix BioMedix and related companies with MarketBeat.com's FREE daily email newsletter.
